Tradipitant: Difference between revisions
CSV import |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Short description|A neurokinin-1 receptor antagonist}} | {{Short description|A neurokinin-1 receptor antagonist}} | ||
[[File:LY686017.svg|Chemical structure of Tradipitant|thumb|right]] | |||
'''Tradipitant''' is a [[neurokinin-1 receptor antagonist]] that has been investigated for its potential therapeutic effects in various conditions, including [[nausea]], [[vomiting]], and [[pruritus]]. It is a small molecule drug that works by blocking the action of [[substance P]], a neuropeptide involved in the transmission of pain and other sensory signals. | '''Tradipitant''' is a [[neurokinin-1 receptor antagonist]] that has been investigated for its potential therapeutic effects in various conditions, including [[nausea]], [[vomiting]], and [[pruritus]]. It is a small molecule drug that works by blocking the action of [[substance P]], a neuropeptide involved in the transmission of pain and other sensory signals. | ||
| Line 24: | Line 24: | ||
In clinical trials, tradipitant has been generally well-tolerated, with a safety profile similar to other neurokinin-1 receptor antagonists. Common side effects may include mild gastrointestinal disturbances, headache, and fatigue. | In clinical trials, tradipitant has been generally well-tolerated, with a safety profile similar to other neurokinin-1 receptor antagonists. Common side effects may include mild gastrointestinal disturbances, headache, and fatigue. | ||
==Related | ==Related pages== | ||
* [[Neurokinin-1 receptor antagonist]] | * [[Neurokinin-1 receptor antagonist]] | ||
* [[Substance P]] | * [[Substance P]] | ||
| Line 30: | Line 30: | ||
* [[Gastroparesis]] | * [[Gastroparesis]] | ||
* [[Motion sickness]] | * [[Motion sickness]] | ||
{{stub}} | |||
[[Category:Neurokinin-1 receptor antagonists]] | [[Category:Neurokinin-1 receptor antagonists]] | ||
[[Category:Antiemetics]] | [[Category:Antiemetics]] | ||
[[Category:Experimental drugs]] | [[Category:Experimental drugs]] | ||
Latest revision as of 13:46, 5 March 2025
A neurokinin-1 receptor antagonist
Tradipitant is a neurokinin-1 receptor antagonist that has been investigated for its potential therapeutic effects in various conditions, including nausea, vomiting, and pruritus. It is a small molecule drug that works by blocking the action of substance P, a neuropeptide involved in the transmission of pain and other sensory signals.
Mechanism of Action[edit]
Tradipitant functions as an antagonist of the neurokinin-1 receptor (NK1R), which is a receptor for substance P. Substance P is a neuropeptide that is involved in the regulation of emesis, pain, and inflammation. By inhibiting the binding of substance P to NK1R, tradipitant can reduce the symptoms associated with these conditions.
Clinical Development[edit]
Tradipitant has been studied in various clinical trials for its efficacy in treating conditions such as chronic pruritus, gastroparesis, and motion sickness.
Chronic Pruritus[edit]
Chronic pruritus, or persistent itching, is a condition that can significantly affect quality of life. Tradipitant has shown promise in reducing itch severity in patients with atopic dermatitis and other pruritic conditions.
Gastroparesis[edit]
Gastroparesis is a disorder characterized by delayed gastric emptying, leading to symptoms such as nausea, vomiting, and abdominal pain. Tradipitant has been evaluated for its potential to alleviate these symptoms by modulating the neurokinin-1 receptor pathway.
Motion Sickness[edit]
Tradipitant has also been investigated for its ability to prevent and treat motion sickness, a condition caused by conflicting sensory signals in the vestibular system. By blocking substance P, tradipitant may help reduce the nausea and discomfort associated with motion sickness.
Pharmacokinetics[edit]
Tradipitant is administered orally and is absorbed into the bloodstream, where it exerts its effects by binding to the neurokinin-1 receptors. The pharmacokinetic profile of tradipitant includes its absorption, distribution, metabolism, and excretion, which are important factors in determining its dosing regimen and potential interactions with other medications.
Safety and Tolerability[edit]
In clinical trials, tradipitant has been generally well-tolerated, with a safety profile similar to other neurokinin-1 receptor antagonists. Common side effects may include mild gastrointestinal disturbances, headache, and fatigue.
